Hematophagocytic syndrome and malignancy: an unexplored relationship
DOI:
https://doi.org/10.33448/rsd-v11i5.28139Keywords:
Hemophagocytic lymphohistiocytosis; Oncology; CancerAbstract
The aim of this study was verify the relationship and implications of neoplasms as triggers for macrophage hyperactivation in secondary hemophagocytic lymphohistiocytosis. A bibliographic survey was carried out on the PubMed platform with selection of relevant articles on the proposed topic using the descriptors “hemophagocytic lymphohistiocytosis” AND “oncology”, including articles published until June 2019. describing the evolution of publications over the years, the modalities of published studies, and selecting clinical studies for description and detail. A total of 4504 published works were found, since 1952. It was observed that there was an increase in the number of publications from the 1990s, especially from 1997. The largest number of publications occurred in 2019. There is still a scarcity of publications on clinical studies on the subject, most of which focus on pediatric populations and patients with hematological tumors. It also demonstrates better benefits in the use of allogeneic hematopoietic stem cell transplantation, in addition to suggesting a change in the diagnostic parameter. Knowing conditions that may be related to oncological disease can improve the comprehensive care of these patients.
References
Ahmed, A., Merrill, S. A., Alsawah, F., Bockenstedt, P., Campagnaro, E., Devata, S., Gitlin, S. D., Kaminski, M., Cusick, A., Phillips, T., Sood, S., Talpaz, M., Quiery, A., Boonstra, P. S., & Wilcox, R. A. (2019). Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. The Lancet Haematology, 6(12), e630–e637. https://doi.org/10.1016/S2352-3026(19)30156-5
Allen, C. E., Marsh, R., Dawson, P., Bollard, C. M., Shenoy, S., Roehrs, P., Hanna, R., Burroughs, L., Kean, L., Talano, J.-A., Schultz, K. R., Pai, S.-Y., Baker, K. S., Andolina, J. R., Stenger, E. O., Connelly, J., Ramirez, A., Bryant, C., Eapen, M., & Pulsipher, M. A. (2018). Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. Blood, 132(13), 1438–1451. https://doi.org/10.1182/blood-2018-01-828277
Al-Samkari, H., & Berliner, N. (2018). Hemophagocytic Lymphohistiocytosis. Annual Review of Pathology: Mechanisms of Disease, 13(1), 27–49. https://doi.org/10.1146/annurev-pathol-020117-043625
Apodaca, E., Rodríguez-Rodríguez, S., Tuna-Aguilar, E. J., & Demichelis-Gómez, R. (2018). Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience. Clinical Lymphoma Myeloma and Leukemia, 18(10), e373–e380. https://doi.org/https://doi.org/10.1016/j.clml.2018.06.014
Chinn, I. K., Eckstein, O. S., Peckham-Gregory, E. C., Goldberg, B. R., Forbes, L. R., Nicholas, S. K., Mace, E. M., Vogel, T. P., Abhyankar, H. A., Diaz, M. I., Heslop, H. E., Krance, R. A., Martinez, C. A., Nguyen, T. C., Bashir, D. A., Goldman, J. R., Stray-Pedersen, A., Pedroza, L. A., Poli, M. C., … Allen, C. E. (2018). Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood, 132(1), 89–100. https://doi.org/10.1182/blood-2017-11-814244
Coffey, A. M., Lewis, A., Marcogliese, A. N., Elghetany, M. T., Punia, J. N., Chang, C.-C., Allen, C. E., McClain, K. L., Gaikwad, A. S., El-Mallawany, N. K., & Curry, C. v. (2019). A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America. Pediatric Blood & Cancer, 66(8), e27798. https://doi.org/https://doi.org/10.1002/pbc.27798
Daver, N., McClain, K., Allen, C. E., Parikh, S. A., Otrock, Z., Rojas-Hernandez, C., Blechacz, B., Wang, S., Minkov, M., Jordan, M. B., la Rosée, P., & Kantarjian, H. M. (2017). A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer, 123(17), 3229–3240. https://doi.org/https://doi.org/10.1002/cncr.30826
Faraci, M., Bertaina, A., Luksch, R., Calore, E., Lanino, E., Saglio, F., Prete, A., Menconi, M., de Simone, G., Tintori, V., Cesaro, S., Santarone, S., Orofino, M. G., Locatelli, F., & Zecca, M. (2019). Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association–Hematopoietic Stem Cell Transplantation Group. Biology of Blood and Marrow Transplantation, 25(2), 313–320. https://doi.org/https://doi.org/10.1016/j.bbmt.2018.09.027
Gassas, A., Ashraf, K., Zaidman, I., Ali, M., Krueger, J., Doyle, J., Schechter, T., & Leucht, S. (2015). Hematopoietic stem cell transplantation in infants. Pediatric Blood & Cancer, 62(3), 517–521. https://doi.org/https://doi.org/10.1002/pbc.25333
Henter, J.-I., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., & Janka, G. (2007). HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 48(2), 124–131. https://doi.org/https://doi.org/10.1002/pbc.21039
Henter, J.-I., Samuelsson-Horne, A., Aricò, M., Egeler, R. M., Elinder, G., Filipovich, A. H., Gadner, H., Imashuku, S., Komp, D., Ladisch, S., Webb, D., Janka, G., & Society, for the H. (2002). Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood, 100(7), 2367–2373. https://doi.org/10.1182/blood-2002-01-0172
Imashuku, S., Teramura, T., Kuriyama, K., Kitazawa, J., Ito, E., Morimoto, A., & Hibi, S. (2002). Risk of Etoposide-Related Acute Myeloid Leukemia in the Treatment of Epstein-Barr Virus—Associated Hemophagocytic Lymphohistiocytosis. International Journal of Hematology, 75(2), 174–177. https://doi.org/10.1007/BF02982023
Lehmberg, K., Sprekels, B., Nichols, K. E., Woessmann, W., Müller, I., Suttorp, M., Bernig, T., Beutel, K., Bode, S. F. N., Kentouche, K., Kolb, R., Längler, A., Minkov, M., Schilling, F. H., Schmid, I., Vieth, S., Ehl, S., zur Stadt, U., & Janka, G. E. (2015). Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. British Journal of Haematology, 170(4), 539–549. https://doi.org/https://doi.org/10.1111/bjh.13462
Locatelli, F., Jordan, M. B., Allen, C., Cesaro, S., Rizzari, C., Rao, A., Degar, B., Garrington, T. P., Sevilla, J., Putti, M.-C., Fagioli, F., Ahlmann, M., Dapena Diaz, J.-L., Henry, M., de Benedetti, F., Grom, A., Lapeyre, G., Jacqmin, P., Ballabio, M., & de Min, C. (2020). Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. New England Journal of Medicine, 382(19), 1811–1822. https://doi.org/10.1056/NEJMoa1911326
Machaczka, M., Vaktnäs, J., Klimkowska, M., & Hägglund, H. (2011). Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leukemia & Lymphoma, 52(4), 613–619. https://doi.org/10.3109/10428194.2010.551153
Moritake, H., Obara, M., Sameshima, N., Asada, Y., Komatsu, H., Hyakuna, N., Sugita, K., Ishida, Y., Kato, M., Tanizawa, A., Deguchi, T., Imamura, T., Kitanaka, A., Shimoda, K., Kamimura, S., & Nunoi, H. (2015). Analysis of the molecular mechanism underlying bone marrow necrosis with acute lymphoblastic leukemia. International Journal of Hematology, 102(3), 349–356. https://doi.org/10.1007/s12185-015-1843-8
Ahmed, A., Merrill, S. A., Alsawah, F., Bockenstedt, P., Campagnaro, E., Devata, S., Gitlin, S. D., Kaminski, M., Cusick, A., Phillips, T., Sood, S., Talpaz, M., Quiery, A., Boonstra, P. S., & Wilcox, R. A. (2019). Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. The Lancet Haematology, 6(12), e630–e637. https://doi.org/10.1016/S2352-3026(19)30156-5
Allen, C. E., Marsh, R., Dawson, P., Bollard, C. M., Shenoy, S., Roehrs, P., Hanna, R., Burroughs, L., Kean, L., Talano, J.-A., Schultz, K. R., Pai, S.-Y., Baker, K. S., Andolina, J. R., Stenger, E. O., Connelly, J., Ramirez, A., Bryant, C., Eapen, M., & Pulsipher, M. A. (2018). Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. Blood, 132(13), 1438–1451. https://doi.org/10.1182/blood-2018-01-828277
Al-Samkari, H., & Berliner, N. (2018). Hemophagocytic Lymphohistiocytosis. Annual Review of Pathology: Mechanisms of Disease, 13(1), 27–49. https://doi.org/10.1146/annurev-pathol-020117-043625
Apodaca, E., Rodríguez-Rodríguez, S., Tuna-Aguilar, E. J., & Demichelis-Gómez, R. (2018). Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience. Clinical Lymphoma Myeloma and Leukemia, 18(10), e373–e380. https://doi.org/https://doi.org/10.1016/j.clml.2018.06.014
Chinn, I. K., Eckstein, O. S., Peckham-Gregory, E. C., Goldberg, B. R., Forbes, L. R., Nicholas, S. K., Mace, E. M., Vogel, T. P., Abhyankar, H. A., Diaz, M. I., Heslop, H. E., Krance, R. A., Martinez, C. A., Nguyen, T. C., Bashir, D. A., Goldman, J. R., Stray-Pedersen, A., Pedroza, L. A., Poli, M. C., … Allen, C. E. (2018). Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood, 132(1), 89–100. https://doi.org/10.1182/blood-2017-11-814244
Coffey, A. M., Lewis, A., Marcogliese, A. N., Elghetany, M. T., Punia, J. N., Chang, C.-C., Allen, C. E., McClain, K. L., Gaikwad, A. S., El-Mallawany, N. K., & Curry, C. v. (2019). A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America. Pediatric Blood & Cancer, 66(8), e27798. https://doi.org/https://doi.org/10.1002/pbc.27798
Daver, N., McClain, K., Allen, C. E., Parikh, S. A., Otrock, Z., Rojas-Hernandez, C., Blechacz, B., Wang, S., Minkov, M., Jordan, M. B., la Rosée, P., & Kantarjian, H. M. (2017). A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer, 123(17), 3229–3240. https://doi.org/https://doi.org/10.1002/cncr.30826
Faraci, M., Bertaina, A., Luksch, R., Calore, E., Lanino, E., Saglio, F., Prete, A., Menconi, M., de Simone, G., Tintori, V., Cesaro, S., Santarone, S., Orofino, M. G., Locatelli, F., & Zecca, M. (2019). Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association–Hematopoietic Stem Cell Transplantation Group. Biology of Blood and Marrow Transplantation, 25(2), 313–320. https://doi.org/https://doi.org/10.1016/j.bbmt.2018.09.027
Gassas, A., Ashraf, K., Zaidman, I., Ali, M., Krueger, J., Doyle, J., Schechter, T., & Leucht, S. (2015). Hematopoietic stem cell transplantation in infants. Pediatric Blood & Cancer, 62(3), 517–521. https://doi.org/https://doi.org/10.1002/pbc.25333
Henter, J.-I., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., & Janka, G. (2007). HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 48(2), 124–131. https://doi.org/https://doi.org/10.1002/pbc.21039
Henter, J.-I., Samuelsson-Horne, A., Aricò, M., Egeler, R. M., Elinder, G., Filipovich, A. H., Gadner, H., Imashuku, S., Komp, D., Ladisch, S., Webb, D., Janka, G., & Society, for the H. (2002). Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood, 100(7), 2367–2373. https://doi.org/10.1182/blood-2002-01-0172
Imashuku, S., Teramura, T., Kuriyama, K., Kitazawa, J., Ito, E., Morimoto, A., & Hibi, S. (2002). Risk of Etoposide-Related Acute Myeloid Leukemia in the Treatment of Epstein-Barr Virus—Associated Hemophagocytic Lymphohistiocytosis. International Journal of Hematology, 75(2), 174–177. https://doi.org/10.1007/BF02982023
Lehmberg, K., Sprekels, B., Nichols, K. E., Woessmann, W., Müller, I., Suttorp, M., Bernig, T., Beutel, K., Bode, S. F. N., Kentouche, K., Kolb, R., Längler, A., Minkov, M., Schilling, F. H., Schmid, I., Vieth, S., Ehl, S., zur Stadt, U., & Janka, G. E. (2015). Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. British Journal of Haematology, 170(4), 539–549. https://doi.org/https://doi.org/10.1111/bjh.13462
Locatelli, F., Jordan, M. B., Allen, C., Cesaro, S., Rizzari, C., Rao, A., Degar, B., Garrington, T. P., Sevilla, J., Putti, M.-C., Fagioli, F., Ahlmann, M., Dapena Diaz, J.-L., Henry, M., de Benedetti, F., Grom, A., Lapeyre, G., Jacqmin, P., Ballabio, M., & de Min, C. (2020). Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. New England Journal of Medicine, 382(19), 1811–1822. https://doi.org/10.1056/NEJMoa1911326
Machaczka, M., Vaktnäs, J., Klimkowska, M., & Hägglund, H. (2011). Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leukemia & Lymphoma, 52(4), 613–619. https://doi.org/10.3109/10428194.2010.551153
Moritake, H., Obara, M., Sameshima, N., Asada, Y., Komatsu, H., Hyakuna, N., Sugita, K., Ishida, Y., Kato, M., Tanizawa, A., Deguchi, T., Imamura, T., Kitanaka, A., Shimoda, K., Kamimura, S., & Nunoi, H. (2015). Analysis of the molecular mechanism underlying bone marrow necrosis with acute lymphoblastic leukemia. International Journal of Hematology, 102(3), 349–356. https://doi.org/10.1007/s12185-015-1843-8
Nagai, K., Ochi, F., Terui, K., Maeda, M., Ohga, S., Kanegane, H., Kitoh, T., Kogawa, K., Suzuki, N., Ohta, S., Ishida, Y., Okamura, T., Wakiguchi, H., Yasukawa, M., & Ishii, E. (2013). Clinical characteristics and outcomes of chédiak–Higashi syndrome: A nationwide survey of Japan. Pediatric Blood & Cancer, 60(10), 1582–1586. https://doi.org/https://doi.org/10.1002/pbc.24637
Oguz, M. M., Sahin, G., Altinel Acoglu, E., Polat, E., Yucel, H., Oztek Celebi, F. Z., Unsal, H., Akcaboy, M., Sari, E., & Senel, S. (2019). Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis. Pediatric Hematology and Oncology, 36(1), 1–16. https://doi.org/10.1080/08880018.2019.1572253
Otrock, Z. K., & Eby, C. S. (2015). Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. American Journal of Hematology, 90(3), 220–224. https://doi.org/https://doi.org/10.1002/ajh.23911
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica.
Ramos-Casals, M., Brito-Zerón, P., López-Guillermo, A., Khamashta, M. A., & Bosch, X. (2014). Adult haemophagocytic syndrome. The Lancet, 383(9927), 1503–1516. https://doi.org/https://doi.org/10.1016/S0140-6736(13)61048-X
Ramzan, M., Yadav, S. P., Kharya, G., Chinnabhandar, V., Enteserian, M., Henter, J. I., & Sachdeva, A. (2014). Hemophagocytic Lymphohistiocytosis in Infants: A Single Center Experience from India. Pediatric Hematology and Oncology, 31(3), 285–292. https://doi.org/10.3109/08880018.2013.862754
Roldão, M. A. O. (2017). Linfohistiocitose hemofagocítica primária e secundária: fisiopatologia, diagnóstico e tratamento.
Sawada, A., Ohga, S., Ishii, E., Inoue, M., Okada, K., Inagaki, J., Goto, H., Suzuki, N., Koike, K., Atsuta, Y., Suzuki, R., Yabe, H., Kawa, K., Kato, K., & Yasutomo, K. (2013). Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan. International Journal of Hematology, 98(2), 223–230. https://doi.org/10.1007/s12185-013-1391-z
Schram, A. M., & Berliner, N. (2015). How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood, 125(19), 2908–2914. https://doi.org/10.1182/blood-2015-01-551622
Shin, H.-J., Chung, J. S., Lee, J.-J., Sohn, S. K., Choi, Y. J., Kim, Y.-K., Yang, D.-H., Kim, H.-J., Kim, J. G., Joo, Y. D., Lee, W. S., Sohn, C.-H., Lee, E. Y., & Cho, G. J. (2008). Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. Journal of Korean Medical Science, 23(3), 439–444. https://doi.org/10.3346/jkms.2008.23.3.439
Souto Moura, T., Simões, I., Lemos, M., Azevedo, L., Gerivaz, R., & Fonseca, P. (2017). Síndrome Hemofagocítica: um Suspeito a Considerar. Medicina Interna, 24, 128–132.
Tabata, Y., Villanueva, J., Lee, S. M., Zhang, K., Kanegane, H., Miyawaki, T., Sumegi, J., & Filipovich, A. H. (2005). Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood, 105(8), 3066–3071. https://doi.org/10.1182/blood-2004-09-3651
Tesi, B., Chiang, S. C. C., El-Ghoneimy, D., Hussein, A. A., Langenskiöld, C., Wali, R., Fadoo, Z., Silva, J. P., Lecumberri, R., Unal, S., Nordenskjöld, M., Bryceson, Y. T., Henter, J.-I., & Meeths, M. (2015). Spectrum of Atypical Clinical Presentations in Patients with Biallelic PRF1 Missense Mutations. Pediatric Blood & Cancer, 62(12), 2094–2100. https://doi.org/https://doi.org/10.1002/pbc.25646
Yildiz, H., van den Neste, E., P. Defour, J., Danse, E., & Yombi, J. C. (2020). Adult haemophagocytic lymphohistiocytosis: a review. QJM: An International Journal of Medicine, hcaa011. https://doi.org/10.1093/qjmed/hcaa011
Zhao, X.-X., Lian, H.-Y., Zhang, L., Ma, H.-H., Wang, D., Zhao, Y.-Z., Liu, Z.-W., Wang, T.-Y., Zhang, R., & Li, Z.-G. (2019). Significance of serum ferritin level in hemophagocytic lymphohistiocytosis diagnosis. International Journal of Laboratory Hematology, 41(4), 503–508. https://doi.org/https://doi.org/10.1111/ijlh.13032
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Larissa Santos Lima; Clariano Pires de Oliveira Neto; Igor Marcelo Castro e Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
